FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philip Rowe

Research Profile

Concepts & Ideas

Chemicals & Drugs

Phenomena

Occupations

Activities & Behaviors

Co-author Network

Publications

TOP 3
Mark Hewitt; Philip H Rowe; Mark T D Cronin; T Wayne Schultz
Repeatability analysis of the Tetrahymena pyriformis population growth impairment assay.
Emma C Davies; CF Green; David R Mottram; Philip H Rowe; Munir Pirmohamed
Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission.
Janet Krska; Philip H Rowe
Outcome measures: a sensitive approach.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philip Rowe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Mark Hewitt; Philip H Rowe; Mark T D Cronin; T Wayne Schultz
Repeatability analysis of the Tetrahymena pyriformis population growth impairment assay.
SAR and QSAR in environmental research 2011;22(5-6):621-37.
2010: Emma C Davies; CF Green; David R Mottram; Philip H Rowe; Munir Pirmohamed
Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission.
British journal of clinical pharmacology 2010;70(5):749-55.
2010: Janet Krska; Philip H Rowe
Outcome measures: a sensitive approach.
The International journal of pharmacy practice 2010;18(2):125-7.
2007: Mark Hewitt; Mark T D Cronin; Judith C Madden; Philip H Rowe; Clara Johnson; Anrdrea Obi; Steven J Enoch
Consensus QSAR models: do the benefits outweigh the complexity?
Journal of chemical information and modeling 2007;47(4):1460-8.
2007: Mark Hewitt; Judith C Madden; Philip H Rowe; Mark T D Cronin
Structure-based modelling in reproductive toxicology: (Q)SARs for the placental barrier.
SAR and QSAR in environmental research 2007;18(1-2):57-76.
2005: N Manga; Judith C Duffy; Philip H Rowe; Mark T D Cronin
Structure-based methods for the prediction of the dominant P450 enzyme in human drug biotransformation: consideration of CYP3A4, CYP2C9, CYP2D6.
SAR and QSAR in environmental research 2005;16(1-2):43-61.
2004: D Brown; James L Ford; A J Nunn; Philip H Rowe
An assessment of dose-uniformity of samples delivered from paediatric oral droppers.
Journal of clinical pharmacy and therapeutics 2004;29(6):521-9.
2004: Matthew Roberts; James L Ford; Graeme S MacLeod; John T Fell; George W Smith; Philip H Rowe; A Mark Dyas
Effect of punch tip geometry and embossment on the punch tip adherence of a model ibuprofen formulation.
The Journal of pharmacy and pharmacology 2004;56(7):947-50.
2004: Matthew Roberts; James L Ford; Graeme S MacLeod; John T Fell; George W Smith; Philip H Rowe; A Mark Dyas
Effect of lubricant type and concentration on the punch tip adherence of model ibuprofen formulations.
The Journal of pharmacy and pharmacology 2004;56(3):299-305.
2003: Matthew Roberts; James L Ford; Graeme S MacLeod; John T Fell; George W Smith; Philip H Rowe
Effects of surface roughness and chrome plating of punch tips on the sticking tendencies of model ibuprofen formulations.
The Journal of pharmacy and pharmacology 2003;55(9):1223-8.
2002: Mark T D Cronin; Aynur O Aptula; Judith C Duffy; Tatiana I Netzeva; Philip H Rowe; Iva V Valkova; T Wayne Schultz
Comparative assessment of methods to develop QSARs for the prediction of the toxicity of phenols to Tetrahymena pyriformis.
Chemosphere 2002;49(10):1201-21.
2002: Mark T D Cronin; Aynur O Aptula; John C Dearden; Judith C Duffy; Tatiana I Netzeva; Hiren Patel; Philip H Rowe; T Wayne Schultz; Andrew P Worth; Konstantinos Voutzoulidis; Gerrit Schüürmann
Structure-based classification of antibacterial activity.
Journal of chemical information and computer sciences 2002;42(4):869-78.
2001: CF Green; David R Mottram; Philip H Rowe; M Pirmohamed
Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting.
British journal of clinical pharmacology 2001;51(1):81-6.
2000: CF Green; David R Mottram; Philip H Rowe; M Pirmohamed
Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study.
Journal of clinical pharmacy and therapeutics 2000;25(5):355-61.
1999: CF Green; David R Mottram; M Pirmohamed; R Horner; Philip H Rowe
Communication regarding adverse drug reactions between secondary and primary care: a postal questionnaire survey of general practitioners.
Journal of clinical pharmacy and therapeutics 1999;24(2):133-9.
1998: O F Akande; James L Ford; Philip H Rowe; M H Rubinstein
The effects of lag-time and dwell-time on the compaction properties of 1:1 paracetamol/microcrystalline cellulose tablets prepared by pre-compression and main compression.
The Journal of pharmacy and pharmacology 1998;50(1):19-28.